Please scroll to bottom:
Adjustments to NIH and AHRQ Grant Application Due Dates Between September 22 and September 30, 2022
Notice Number:NOT-OD-22-190
Colleagues—below is a link to a Notice in the Guide to alert potential NIH applicants to a change in the receipt date for applications due between Sept 23 and Sept 30, 2022. The new receipt date will be October 3, 2022 to allow the migration of grants.gov to the cloud. The notice also contains information on continuous submission and AIDS applications due dates. Please disseminate this information widely. Thanks.
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-190.html
-----
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Notice Number: PAR-20-225
Application deadline October 19, 2022 by 5:00PM local time of applicant organization.
Funding Opportunity Purpose:
Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies.
The Genetics or Epigenetics of Substance Use Disorders Avenir Award program supports early-stage investigators proposing highly innovative studies that open new areas of research for the genetics or epigenetics of addiction. These may be novel methods or approaches that can potentially be applied to the analysis of the genetics or epigenetics of addiction. Investigators outside the field of addiction interested in applying their novel approaches to the genetics or epigenetics of addiction are encouraged to apply. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field of genetics or epigenetics of substance use disorders.https://grants.nih.gov/grants/guide/pa-files/PAR-20-225.html
----------
Call For Applications. The 2022 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention calls for applications for the Early Career Investigator Showcases (ECIS). The ECIS symposium provides a forum for scientific presentations by premier young and junior investigators working in the fields of alcohol and substance misuse and addiction research. This symposium will take place on Tuesday and Wednesday, November 1-2, 2022, during the Annual NIDA-NIAAA Frontiers in Addiction Research Mini-Convention. To apply, please complete the application form, include your Curriculum Vitae/Resume and list of publications, and send via email to (ECIS.Abstracts@seiservices.com) by Friday, September 2, 2022, 5:00 PM (EDT).
For additional information, please contact: for NIDA [Anne Tsai, stsai@nih.gov] or for NIAAA [John Matochik, jmatochi@mail.nih.gov
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L
No comments:
Post a Comment